Maxcyte (MXCT) Change in Receivables (2020 - 2026)
Maxcyte (MXCT) reported Change in Receivables of $743000.0 for Q1 2026, down 11.44% year-over-year from $839000.0 in Q1 2025, and up 115.49% quarter-over-quarter from -$4.8 million in Q4 2025.
Maxcyte (MXCT) Change in Receivables (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Change in Receivables data on file, last reported at $743000.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $743000.0, down 11.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 70.41% YoY), and the FY2025 annual result was -$1.1 million, up 6.36% from the prior year.
- Change in Receivables climbed to $743000.0 in Q1 2026 per MXCT's latest filing, from -$4.8 million in the prior quarter.
- Over five years, Change in Receivables peaked at $4.0 million in Q4 2022 and troughed at -$4.8 million in Q4 2025.
- A 5-year average of -$134588.2 and a median of $122000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 46455.56% in 2023, then tumbled 4031.97% in 2025.
- A 5-year view of Change in Receivables shows it stood at $4.0 million in 2022, then plunged by 141.25% to -$1.7 million in 2023, then surged by 107.37% to $122000.0 in 2024, then plunged by 4031.97% to -$4.8 million in 2025, then jumped by 115.49% to $743000.0 in 2026.
- Business Quant data shows MXCT's Change in Receivables at $743000.0 in Q1 2026, -$4.8 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 117.90 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -141.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -124.60 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Maxcyte | 120.23 Mn | 120.23 Mn | 8.08 Mn | 743,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 743,000.00 |
| Mar 31, 2026 | 743,000.00 |
| Dec 31, 2025 | -4.80 Mn |
| Dec 31, 2025 | -4.80 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -1.67 Mn |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | 343,000.00 |
| Mar 31, 2024 | 343,000.00 |
| Dec 31, 2023 | -1.66 Mn |
| Dec 31, 2023 | -1.66 Mn |